# Zilver PTX Post-Market Study in Japan

> **NCT02254837** · NA · COMPLETED · sponsor: **Cook Group Incorporated** · enrollment: 909 (actual)

## Conditions studied

- Peripheral Arterial Disease (PAD)

## Interventions

- **DEVICE:** Zilver PTX Drug-Eluting Stent

## Key facts

- **NCT ID:** NCT02254837
- **Lead sponsor:** Cook Group Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 909 (ACTUAL)
- **Last updated:** 2019-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02254837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02254837, "Zilver PTX Post-Market Study in Japan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02254837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*